SALT POINT STRATEGIES

Lobbying for THE RITEDOSE CORPORATION · Pharmaceutical CDMO and Generics Manufacturer.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · South Carolina · House · Senate · $90,000.00 income · posted Jan 18, 2026

Lobbying activity 3

Trade (domestic/foreign)

Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.

Tariff (miscellaneous tariff bills)

Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.

Manufacturing

Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.